Integration of human papillomavirus (HPV) DNA into the host cell genome is believed to be essential for malignant progression. However unambiguous detection of the physical state of HPV is a difficult and timeconsuming procedure. To resolve this issue a simple, rapid and highly sensitive technique of polymerase chain reaction (PCR) has been utilized for detecting the physical state of HPV-16 DNA. Investigations were carried out in 122 cervical specimens comprising the whole spectrum of cervical lesions starting from cervical dysplasia to invasive carcinoma including HPV-16-positive normal controls. A pair of oligonucleotide primers specific to the E2 open reading frame, which is often deleted or disrupted following HPV integration, was used for the study. Distinction between episomal and integrated forms of viral DNA was accomplished by detecting amplification of the E2-specific fragment (1139 bp) in the PCR product. The PCR results were compared with those obtained by the conventional methods of Southern blotting, twodimensional gel electrophoresis and chromosomal in situ hybridization; a high degree of agreement was observed between the methods. The findings indicate that although integrated forms of HPV-16 DNA were detected in more than 70% of cervical cancer specimens, integration was less frequent (23%) in severe dysplasia and carcinoma in situ. Only 2.5 % of cases showed both episomal and integrated forms ofHPV-16 DNA. The difference between episomal and integrated forms was statistically significant (P<0.01). The absence of integration in about 30% of cancer cases suggests that integration of HPV may not be necessary for malignant progression and alternative mechanism(s) of malignant transformation may occur without HPV integration. The PCR test thus provides an effective complement to Southern blotting and twodimensional gel electrophoresis for accurate detection of the integration of HPV DNA.
Introduction
Cancer of the uterine cervix is the most common -malignant tumour in Indian women (Luthra et al., 1987; WHOBulletin, 1986; Murthy et al., 1990) . Infection with specific human papillomavirus (HPV) types has been considered to be the major aetiological factor for the development of this disease (Diirst et al., 1983; zur Hausen, 1989b) . In India as many as 98% of cervical carcinoma cases are found to harbour HPV DNA , a frequency not seen in other countries. The most prevalent type is HPV-16 while the frequency of HPV-18 and other types is either very low or zero (Pfister, 1987; Gissmann et al., 1987; Das et al., 1989 Das et al., , 1992 . Since it is generally believed that integration of viral DNA into the host cell genome may be an essential prerequisite for malignant progression (Dtirst et al., 1985; Gissmann et al., 1987; Schneider-Maunoury et al., 1987; zur Hausen, 1989a) , there hive been several studies (Baker et al., 1987; Boshart et al., 1984; Diirst et al., 1986; Gissmann et al., 1984; Lehn et al., 1985; McCance et al., 1983; Riou et al., 1985; Spence et al., 1988) analysing the physical state of HPVs which may serve as a prognostic indicator for the preneoplastic lesions that are likely to progress to cancers. Furthermore it may offer clue(s) for understanding the mechanism(s) involved during the process of cervical carcinogenesis.
All these studies have utilized standard methodologies involving a number of Southern blots and two-dimensional (2D) gel electrophoresis, techniques which are cumbersome and ti~e-consuming and require a large amount of biopsy DNA. Since biopsies are generally not available from preneoplastic or early neoplastic lesions and as the yield of DNA from cervical scrapes of normalJy small cervical dysploasias is often inadequate, we have designed a pair of oligonucleotide primers to detect the physical state of HPV by polymerase chain reaction (PCR).
It is known that integration of HPV usually disrupts or deletes the E1 or E2 open reading frames (ORFs) E2-1 5'-AGG ACG AGG ACA AGG AAA A-3' 2734~2753 1139 E2-2 5'-GGA TGC AGT ATC AAG ATT TG-3' 3853-3872 URR-1 5'-AAG GCC AAC TAA ATG TCA C-3' 7763-7781 217 URR-2 5'-CTG CTT TTA TAC TAA CCG G-3' 57-75 E6-1 5'-ATG CAC CAA AAG AGA ACT GC-3' 83-102 477 E6-2 5'-TTA CAG CTG GGT TTC TCT AC-3' 540-559 E7-1 5'-TGC ATG GAG ATA CAC CTA CA-3' 563-582 291 E7-2 5"-GGT TTC TGA GAA CAG ATG GGG-3" 834-854 fl-Globin-1 5'-GAA GAG CCA AGG ACA GGT AC-3' 268 fl-Globin-2 5'-CAA CTT CAT CCA CGT TAC ACC-3' (Awady et al., 1987; Choo et al., 1987 Choo et al., , 1988 Schwarz et al., 1985) , which could lead to over-expression of E6/E7 oncoproteins and subsequent malignant transformation (Choo et al., 1988; Schwarz et al., 1985) . If this is true, there will be an absence of amplification of the E2 gene sequences in the PCR product following integration, or vice versa. Based on this hypothesis, a pair of oligonucleotide primers from the downstream E2 ORF of the HPV-16 genome has been synthesized and used for the present study to analyse the physical state of the virus in tumour DNA. The PCR results were compared to those obtained by Southern blotting, 2D gel electrophoresis and in situ hybridization to confirm the specificity and reliability of the PCR technique. We report that the PCR method offers easy detection of unintegrated viral DNA sequences and provides an effective complement to Southern blotting and 2D gel electrophoresis for accurate analysis of the physical state of HPV DNA.
Methods
Study population and specimens. A total of 21 carcinoma in situ (CIS) and 59 specimens of different grades of dysplasias including 10 normal controls, which were diagnosed histo-or cytopathologically (see Table  1 ) and found positive for HPV-16 DNA, were used for the present study. Also, 42 HPV-16-positive invasive carcinoma specimens, which had been analysed earlier for the physical state of HPV by combined restriction digestion and 2D gel electrophoresis, were also employed for the PCR test.
DNA extraction. The tissue biopsies collected in culture medium (Dulbecco's MEM) were immediately divided into three parts. One part was used for histology and a second part for chromosome preparation. The rest was kept frozen in a deep freezer (at -70 °C) and was later used for DNA extraction. The detailed DNA extraction method is described elsewhere . Briefly, following homogenization in 2 ml of 10 mM-Tris-HCl and 1 mM-EDTA (pH 8.0), the tissue was suspended in equal volumes of 3 ~ SDS/Sarkosyl and digested with 100 ~tg/ml proteinase K (Boehringer-Mannheim) for 1 to 2 h at 37 °C. DNA was extracted with phenol-chloroform-isoamyl alcohol three times. DNA was precipitated with 3 M-sodium acetate (pH 5.0) and absolute ethanol. Cervical scrapes from dysplasia cases and normal controls were collected in PBS and DNA was extracted according to a newly developed method employed routinely in our laboratory. The purity and concentration of DNA was determined in ethidium bromide-stained mini-gels.
Restriction enzyme digestion and gel electrophoresis. 
2D gel electrophoresis.
To differentiate between linear and circular extrachromosomal HPV DNA molecules, 2D gel electrophoresis was done using undigested/sheared DNA or DNA incubated with a no-cut enzyme, HindIII-digested turnout DNA. Following separation in a 0-4% agarose gel in the first dimension, DNA was again electrophoresed in the second dimension in 0,8 % agarose gels (Diirst et al., 1985; Wettstein & Stevens, 1982) .
Southern blot and hydridization. After electrophoresis the gels were stained in ethidium bromide and photographed under a short-wave u.v. transilluminator. Gel-separated tumour DNA was transferred on to Gene-Screen Plus membranes (DuPont) by the method of Southern (1975) with certain modifications. Following prehybridization at 42 °C for 1 to 2 h, the filters were hybridized with a 32p-labdled HPV-16 probe (Diirst, 1987) . Prototype HPV-16 DNA was made vector-free using gel electrophoresis, purified on a DEAE membrane and was nick-translated to a specific activity of 1 × 108 to 2 x 108 c.p.m./l*g DNA. Hybridization was performed under stringent conditions (Tin -20 °C). The hybridization mix contained 50~ formamide, 5 x SSC, 0.02~ Denhardt's solution, 0-25 lag/ml tRNA and 50 mM-Na3PO4 and incubation was at 42 °C for 16 to 20 h. One genome equivalent of HPV-16 DNA (10 pg) was used as a positive control marker to check the sensitivity of hybridization.
Dot blot hybridization.
Six to eight lag of DNA extracted from cervical scrape cell samples was denatured at 65 °C for 30 rain and then chilled immediately on ice and blotted onto a nitrocellulose membrane using a dot blot apparatus (Minifold I; Schleicher & SchfiU). After either baking at 80 °C for 1 h or cross-linking under u.v. light, the membrane was hybridized under stringent conditions (Tm -20 °C) using 32p. labelled HPV probes.
PCR. For detection of integration, two specific oligoprimers from the downstream E20RF of the HPV-16 genome between nucleotides 2734 and 3872 were used. In addition, oligonucleotide primers from the upstream regulatory region (URR) and E6/E70RFs of HPV-16 and a pair of primers from the human//-globin gene were used to check HPV positivity as well as the purity of tumour DNA for the PCR test. The primers were synthesized in an Applied Biosystems DNA Synthesizer (Model 381A, Applied Biosystems) and were purified in NAP-10 columns (Pharmacia). The primer sequences are presented in Table 1. PCR amplification (Saiki et al., 1988) was carried out using about 50 to 100 ng of purified tumour DNA in 50 or 100 ~tl reaction mix containing 1 p.M of each primer, 50 mM-KC1, 10 mM-Tris-HCl pH 8.3, 2-5 mM-MgC12, 75 gg/ml BSA, 200 ~tM of each dNTP and 1 to 2 units of Taq DNA polymerase (Cetus Corporation). The reaction mix was overlaid with 50 ~tl mineral oil in order to avoid evaporation. Amplification was done for 35 to 40 cycles in a Cetus DNA Thermal Cycler (Perkin-Elmer Cetus). The first cycle was 94 °C for 5 min (denaturing), 55 °C for 1 min (annealing) and 72 °C for 2 min (extension) followed by 38 cycles each at 94 °C for 1 min, 55 °C for 1 rain and 72 °C for 2 min. The last cycle was as above except that the extension period at 72 °C was extended up to 7 rain. After amplification, 15 to 20 ~tl of the mix was electrophoresed in a 3% Nusieve-agarose gel with ethidium bromide and photographed under a u.v. transilluminator.
Chromosome preparation from turnout biopsy specimens and in situ hybridization. To confirm integration of HPV DNA into host cell chromosomes, attempts were made to visualize integration sites in tumour chromosomes by in situ hybridization. A part of the biopsy specimen collected in tissue culture medium (DMEM) was immediately processed for either direct preparation or primary culturing for chromosome preparation.
Chromosome preparation. The free tumour cells along with minced tumour tissue were incubated at 37 °C in 5 ml medium supplemented with serum and colcemid (0.02 btl/ml) for 5 to 6 h. Following centrifugation the cell pellet was given a hypotonic treatment for 15 to 20 rain in 0-75 M-KC1 and the cells were fixed in methanol : acetic acid (3 : 1) fixative and washed three or four times in fresh fixative. Air-dried chromosome slides were prepared by making a final cell suspension in 0-5 ml freshly prepared chilled fixative.
Alternatively, a part of the tumour tissue was denatured by trypsin or collagenase treatment, washed in PBS and cultured in DMEM supplemented with 10~ foetal calf serum (FCS) and antibiotics. Within 7 to 10 days when the culture was almost confluent, it was harvested for chromosome preparation following prolonged colcemid treatment.
In situ hybridization. Chromosome in situ hybridization was carried out using a method used for single copy gene localization (Neel et al., 1982) . A vector-purified 8 kb insert of HPV-16 was nick-translated to a specific activity of I × 108 or 2 × 108 c.p.m./~tg DNA using three 3H-labelled nucleotides (dTTP, dCTP and dATP, Amersham). Following proteinase K and RNase treatment of slides, the chromosomal DNA was denatured in 70~ formamide in 2 x SSC for 3 min. Hybridization was performed for 48 h at 42 °C in a moist chamber. Following washing and drying, the slides were coated with Kodak NTB II or III nuclear track emulsion (Eastman Kodak) in the dark, and were stored in the dark at 4 °C under moisture-free conditions for 5 to 6 weeks. The slides were developed in D-19b developer, stained in 5~ Giemsa in phosphate buffer pH 6.8 and observed under a Zeiss photomicroscope (Germany) using oil immersion objectives.
Results

Presence of HPV-16 genome in all invasive cervical carcinoma, CIS and dysplasia cases
All invasive cervical cancer biopsy specimens diagnosed histopathologically were initially screened using the 32p_ labelled vector-free 8 kb insert of HPV-16. PstI, a multicut enzyme for HPV-16, was used to detect authentic restriction fragments of the viral genome. Forty-two HPV-16-positive specimens which showed the characteristic PstI cleavage pattern, i.e. 2-8, 1.9, 1.6, 1.0 and 0.5 kb bands, and had at least five to 10 copies of the viral genome were selected for the analysis of the physical state. The autoradiogram presented in Fig. 1 shows the PstI-specific fragments (arrows)of HPV-16. There are cases (lanes 3 and 4) which showed a very high copy number of HPV-16 including certain genomic rearrangements and the presence of off-sized fragments. All these HPV-16-positive specimens were employed for physical state analysis by four different molecular techniques. Since the amounts of DNA extracted from cervical scrapes of dysplasia and control cases were insufficient, these were confirmed by dot blot hybridization and the physical state was analysed by PCR only. All 122 HPV-16-positive samples were found to show amplification of both HPV-16-specific primers as well as the fl-globin gene in PCR (See Fig. 2 ). Only two cases (4.76%) revealed the presence of both episomal and integrated forms; in these we did not observe either off-sized bands or E2 amplification (see Tables 2 and 3) . (Table 2 ). This confirmed the integrated state of HPV-16 D N A in a majority of invasive cervical cancers. 
Absence of PCR amplification of E20RF primers in the majority of cervical cancer specimens
It is generally accepted that because of integration the E2 ORF region of the HPV genome is deleted or disrupted (Awady et al., 1987; Choo et al., 1987 Choo et al., , 1988 Schwarz et al., 1985) . If this is true, there will be no amplification of the E2 seqeunces in PCR. In the present study, out of 42 invasive carcinoma samples only 11 showed amplification and the others showed no amplification of the expected 1139 bp fragment (see Fig. 6a ). In two samples off-size fragments and linear DNA molecules could not be detected, suggesting an episomal configuration. However, as these samples also failed to show E2 amplification, suggestive of integration, they may contain episomal as well as integrated forms (Table 3) . Using PCR, 73-8~ (31/42) were found to be in integrated forms whereas only 26.2~ (11/42) were in the episomal form (Tables 2 and 3 ). Fig. 6 (a) shows the results from eight carcinoma samples; only three (lanes 4, 6 and 7) were found to contain integrated HPV DNA, as revealed by the absence of amplification.
The majority of precancerous lesions show amplification of the E20RF sequences
Since the amount of DNA extracted from cervical scrapes of dysplasia and CIS cases was not sufficient to carry out Southern blotting and 2D gel electrophoresis, these were analysed by PCR only. Of 49 dysplasia cases, consisting of 22 mild, 17 moderate and 10 severe dysplasias, all showed E2 amplification except one (2.04~); an absence of amplification was recorded in five cases (23.8~o) of 21 CIS specimens analysed. Only one case (4.76) revealed HPV in both the episomal and integrated states (see Table 2 ). Fig. 6 (b) shows the results for eight representative CIS samples of which only one (lane 1) showed the absence of E2 amplification, hence integration. The last two lanes (lanes 9 and 10) in the lower panel are control male and female lymphocyte DNA. All the 10 normal controls showed the presence of extrachromosomal DNA as scored by the appearance of a 1139 bp E2-specific band in PCR.
In situ detection of HPV-16 DNA integration in tumour chromosomes
In a preliminary attempt, chromosomes from only three invasive cancer biopsy specimens which were also analysed by other methods could be prepared by a direct method for visualization of integration sites on chromosomes. Mostly polyploid cells were observed with chromosome numbers varying from 60 to 70 with a mode of 66 chromosomes. Various structural abnormalities were also observed. Fig. 7(a, b) shows the in situ B. C. Das and others hybridization and integration sites (arrows) of HPV-16 DNA in tumour chromosomes. There are three integration sites in Fig. 7 (a) whereas 7 (b) shows four integration sites. It appears from the grain concentration that the HPV copy number may vary from about five (Fig. 7b) to 50 (Fig. 7a) . In view of their poor morphology and inadequate number of metaphases, no attempts were made to band and identify the chromosomes. The three specimens in which in situ localization could be done had already been found to have integrated forms of HPV DNA by three other molecular approaches. HPV DNA in the same specimen (Fig. 7a) can be seen integrated in Fig. 3(b) , 5(a, b) and 6(a), lane 4. 
Discussion
Observation of PstI-specific restriction fragments for HPV-16 on Southern blotting is generally taken to be a reliable method for detection of the viral genome in cervical lesions. As shown in Fig. 1 we have detected the characteristic PstI cleavage pattern of HPV-16 in all HPV-I 6-positive cervical cancer specimens and this is in Fig. 7 . Directly prepared metaphase chromosomes from invasive cancer biopsy specimens showing HP¥-16 integration sites involving three chromosomes (a) or four chromosomes (b) (arrows). Chromosome slides were hybridized with 3H-labeUed dTTP, dCTP and dATP under stringent conditions and coated with Kodak NTB II nuclear track emulsion.
agreement with earlier reports (Yoshikawa et al., 1985; Scholl et al., 1985 ; Lancaster et al., 1986; Meanwell et al., 1987) . However some samples showed deletions or certain genomic rearrangements leading to an atypical pattern which also may be indicative of integration of HPV-16 DNA into the host cell genome (Lehn et al., 1985; Millan et al., 1986; Choo et al., 1987; Takebe et al., 1987; Wilczynski et al., 1988) . In almost all cases, two PstI fragments, i.e. 1.9 and 1.6 kb, representing the E6/E7 and L1/L2 regions respectively, are found to be maintained (Fig. 1) . This indicates that the presence of these specific viral sequences are essential for maintenance of a malignant phenotype.
It has been reported that HPVs such as types 6 and 11 detected in benign lesions and warts are often present in an episomal form (McCance et al., 1983; whereas HPV types 16 and 18 associated with invasive cervical cancers and CIS are usually integrated into the host genome (D(irst et al., 1985; Schwarz et al., 1985; Lehn et al., 1985; Riou et al., 1985; zur Hausen, 1989b) . These two oncogenic HPVs have also been shown to be in an integrated form in a majority of established cell lines derived from cervical carcinomas Yee et al., 1985; Tsunokawa et al., 1986 , Mincheva et al., 1987 Baker et al., 1987; Spence et al., 1988) . It is, therefore, suggested that integration of viral DNA into the host genome may be an essential prerequisite for malignant transformation. In the present study, as many as four different molecular techniques were employed (see Table 3 ) and the results indicate about 70~ integration of HPV-16 DNA in cervical cancer specimens. The basis of our interpretation was as follows. (i) Combined digestion with no-cut (HindlII), single-cut (BamHI) and multi-cut (PstI) enzymes and comparison of band patterns with that of undigested DNA, irrespective of copy number and minor rearrangements ofHPV DNA (Fig. 3a, b) , showed off-sized bands. The detection of bands larger than 23-1 kb (see Fig. 3 b) in lanes UD and SC was indicative of integration. In addition the presence and/or shifting in the size of offsized fragments in lanes SC and MC in Fig. 3(b) together with the authentic BarnHI and PstI cleavage pattern respectively, suggests integration of head-to-tail tandem repeats at more than one site (Dfirst et al., 1983; Seedorf et al., 1985) . All the off-sized fragments detected cannot be due to minor rearrangements only. (ii) These results were confirmed by 2D gel electrophoresis in which linear and circular forms of viral DNA can be differentiated (see Fig. 4a, b and 5a, b) . The detection of a single track of linear HPV DNA molecules rather than the circular DNA track that is characteristic of the episomal form is considered to be due to an integrated state of viral DNA. (iii) There was no PCR amplification of specific oligoprimers from the downstream E2 ORF (see Fig. 6a,  b) , since viral integration leads to disruption or deletion of E1 and E2 ORFs and perhaps deregulation of expression of other early genes (Schwarz et al., 1985; Lehn et al., 1985; Choo et al., 1987; Baker et al., 1987; Cripe et al., 1987; Shirasawa et al., 1988; Takebe et al., 1987; Wilczynski et al., 1988) . (iv) Finally, we used in situ localization and visualization of HPV-16 DNA integration sites in tumour chromosomes (see Fig. 7a, b) .
There was a high degree of agreement between the observations obtained by these four different techniques, which overall demonstrate that integrated forms of HPV-16 DNA are present in a majority (69 ~) of cervical cancer specimens (Table 2 ). This is in accordance with the findings of several authors (Diirst et al., 1985 , Diirst, 1987 Lehn et al., 1985; Riou et al., 1985; zur Hausen, 1989b; Cullen et al., 1991) but is not in conformity with the recent report of Matsukura et al. (1989) who showed that the frequency of integration of HPV-16 DNA in cervical carcinoma is only 30 ~o compared to the 70 ~o that we and others have observed.
Unambiguous detection of the physical state of HPV DNA in tumour DNA specimens is a difficult and cumbersome procedure. Generally, it poses problems when both episomal as well as integrated forms are present in a specimen, or a small sequence of HPV DNA is integrated. Thus there have been several conflicting reports (Cullen et al., 1991 ; DiLuca et al., 1986; Lehn et al., 1988; Matsukura et al., 1989) . To resolve this issue, the present study was initiated to develop a convenient and sensitive method for detection of HPV DNA integration. Because of its high sensitivity, the recently developed PCR (Saiki et al., 1988 ) is rapidly becoming the preferred method for various diagnostic purposes. The present PCR results compare well with those obtained by standard procedures. In turnout DNA specimens, the frequent lack of amplification of E2 ORF sequences indicates that the E2 region is preferentially disrupted or deleted due to integration of HPV. The results for 42 carcinoma samples which were analysed by both Southern blotting and 2D gel methods are largely comparable with those obtained by the present PCR method. This was further confirmed by visualization of HPV DNA integration sites in tumour chromosomes prepared directly from the same tissue specimens (Fig.  7a, b) . The PCR method thus facilitates the detection of a low level of HPV integration which may not be detected by conventional methods. It allows processing of a large number of samples at a time and requires a small amount of turnout DNA. However, to rule out the possibility of integration outside the 1139 bp region or at the El ORF region, additional sets of primers from these regions may have to be used for further confirmation. Alternatively, amplification of virus--cell junctions could be most appropriate, although it would be difficult to know the 'fusion sequences' of the junctions for every case without cloning and sequencing. Nevertheless, since PCR results are in good agreement with the results obtained by standard procedures, it can be reliably used for rapid analysis of the physical state of oncogenic HPV-16. This is most useful in screening pre-neoplastic or early neoplastic lesions from which biopsies are generally not available and the yield of DNA from scraped cervical cells is often inadequate.
Although there are reports that about 50~ of integration events occur in preneoplastic lesions, particularly those of CIN III cases (DiLuca et al., 1986; Lehn et al., 1988) , we could detect only 19~ (n = 31) integration in these cases (severe dysplasia and CIS cases) (see Table 2 ). This is in sharp contrast to the recent report of Cullen et al. (1991) who could detect only 3~ integration in these cases. Observation of such a low frequency of integration may be due to either geographic variation or non-detection of small integrated sequences by conventional methods. The PCR test, therefore, can provide an effective complement to Southern blotting or 2D gel electrophoresis for an accurate detection of the physical state of HPV DNA.
Although it has been suggested that integration of HPV DNA into the host cell genome is essential for malignant progression (Diirst et al., 1985; Schneider-Maunoury et al., 1987; zur Hausen, 1989a, b) it seems unlikely that integration alone is sufficient to account for malignant proliferation. This is not only because of the absence of integration in about 30 ~ of carcinomas as observed by us and others (Cullen et al., 1991) but is also supported by evidence from cell hybrids produced by fusion of HeLa cells and normal human fibroblasts or keratinocytes (Stanbridge, 1976) . These hybrids contained HPV-18 in an integrated form but the malignant phenotype was not expressed (Schwarz et al., 1987; Stanbridge et al., 1982) . Therefore a detailed understanding of the expression of HPV transforming genes, E6/E7, along with other growth regulatory cellular genes following infection by HPV may throw light on the mechanisms involved during the malignant progression of cervical lesions.
